SCHEMBL1666468

SCHEMBL1666468

O=C1NCCC2(CCC(C(=O)OCc3ccccc3)C2)O1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.42
PKM P14618 1/20 0.42
GLA P06280 1/20 0.42
BACE1 P56817 1/20 0.40
TSHR P16473 1/20 0.40
HPGD P15428 1/20 0.39
DDB1 Q16531 1/20 0.39
CRBN Q96SW2 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ELANE P08246 1/20 0.37
FKBP1A P62942 3/20 0.37
ALDH1A1 P00352 1/20 0.37
FABP7 O15540 1/20 0.36
FABP5 Q01469 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16214740 0.90 TSHR (0.44) GAAPKMGLABACE1TSHR
SCHEMBL1812580 0.79 OPRK1 (0.48) GAATSHRHPGDNPC1RAB9A
SCHEMBL6120052 0.75 SMN1; SMN2 (0.46) GAAPKMBACE1TSHRHPGD
SCHEMBL15457715 0.74 SLC6A2 (0.45) GAAPKMTSHRHPGDL3MBTL1
SCHEMBL30148934 0.74 ALDH1A1 (0.46) GAAPKMBACE1TSHRHPGD
SCHEMBL3617827 0.74 SLC6A2 (0.45) GAAPKMTSHRHPGDL3MBTL1
SCHEMBL30148856 0.73 TSHR (0.47) GAAPKMTSHRHPGDL3MBTL1
SCHEMBL11963583 0.72 TSHR (0.44) GAAPKMBACE1TSHRHPGD
SCHEMBL850188 0.72 FABP7 (0.50) GAAPKMTSHRHPGDDDB1
SCHEMBL1668432 0.72 SMN1; SMN2 (0.43) GAAPKMBACE1TSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2486034-A1 SPIROCYCLIC COMPOUNDS AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Bristol-Myers Squibb Company (US) 2012-08-15 EP disclosed
WO-2011044197-A1 SPIROCYCLIC COMPOUNDS AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB COMPANY (US) 2011-04-14 WO disclosed